GeneHarbor Biotech

GeneHarbor Biotech is a Hong Kong-based biotechnology company specializing in the development and manufacturing of high-value health products through proprietary enzymatic synthesis technology. The company is best known for its large-scale production of Nicotinamide Mononucleotide (NMN), a precursor to NAD+ aimed at anti-aging and metabolic health. GeneHarbor operates a sophisticated platform that replaces traditional chemical synthesis with more efficient and environmentally friendly enzymatic processes. Their product portfolio includes various nutritional supplements, pharmaceutical intermediates, and cosmetic ingredients. With a significant manufacturing presence in mainland China, the company serves global markets in the longevity and wellness sectors.